ESR1 and fatty liver disease: Circulating miRNAs (e.g., miR-122, miR-34a) and epigenetic markers (e.g., HNF4A methylation) show promise for reflecting BPA-induced hepatic steatosis and ERα-mediated lipid dysregulation (127, 130).